sildenafil-citrate and Aortic-Coarctation

sildenafil-citrate has been researched along with Aortic-Coarctation* in 2 studies

Reviews

1 review(s) available for sildenafil-citrate and Aortic-Coarctation

ArticleYear
The eye in CHD.
    Cardiology in the young, 2018, Volume: 28, Issue:8

    In recent years, there has been a rise in the number patients with CHD surviving into adulthood. Many have complications related to their CHD or its treatments, outside the heart, including ocular abnormalities. The objective of this review is to highlight the ocular abnormalities that occur in adults with CHD, either from their condition or related to the common drugs prescribed to manage it. In particular, we reviewed the effects of cyanosis, coarctation of the aorta, endocarditis, and the side effects of Sildenafil and Amiodarone. A change in the retinal vasculature is a common observation with cyanosis or coarctation of the aorta. Occlusion of the retinal vessels may also be observed in cyanotic patients, as well as those with infectious endocarditis. Sildenafil has established ocular side effects; here they are explored in the context of therapy for pulmonary hypertension. Similarly, Amiodarone has established ocular risks, which are summarised. The high prevalence of ocular consequences in adult CHD patients reinforces the need for knowledge of the risks involved and for frequent ophthalmological screening where appropriate.

    Topics: Adult; Amiodarone; Aortic Coarctation; Cyanosis; Endocarditis; Eye Diseases; Heart Defects, Congenital; Humans; Retinal Vessels; Sildenafil Citrate

2018

Other Studies

1 other study(ies) available for sildenafil-citrate and Aortic-Coarctation

ArticleYear
[Prophylactic treatment of oral sildenafil citrate for pulmonary hypertension in an infant treated with inhaled nitric oxide after open-heart surgery].
    Kyobu geka. The Japanese journal of thoracic surgery, 2005, Volume: 58, Issue:13

    A 3-month-old boy with coarctation of the aorta (CoA), ventricular septal defect (VSD), atrial septal defect, and severe pulmonary hypertension (PH) underwent one-stage repair consisting of patch closure of VSD and coarctation repair. Inhalation of nitric oxide (iNO) was commenced to treat residual severe PH on the day of the operation. Oral sildenafil citrate was commenced on the day 1 and iNO was gradually weaned off on the day 3. There was no "rebound", severe increase in pulmonary artery pressure, which commonly occurs after discontinuation of iNO. Then the patient was extubated without any difficulties or recurrent PH. The oral sildenafil citrate therapy was ceased on the day 8. Prophylactic use of oral sildenafil citrate for PH might be an useful alternative to shorten the duration of iNO therapy and intensive care unit (ICU) stay in the selected patients after congenital open heart surgery.

    Topics: Administration, Inhalation; Administration, Oral; Aortic Coarctation; Bronchodilator Agents; Cardiac Surgical Procedures; Child, Preschool; Heart Septal Defects, Atrial; Heart Septal Defects, Ventricular; Humans; Hypertension, Pulmonary; Male; Nitric Oxide; Piperazines; Postoperative Period; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents

2005